The Patent Finder

Alexis Biotech Limited

Also on record
Records under this name other than patents Alexis Biotech Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 3 of 3 · Back to Alexis Biotech Limited

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,268,219Method for producing or enhancing a T-cell response against a target cell using a complex comprising an HLA class I molecule and an attaching means
Lapsed on the fee record
Ended Sep 11, 2015 · USPTO record
Lapsed on the fee recordEnded Sep 11, 2015USPTO record
US 7,264,965Method for producing or enhancing a T-cell response against a target cell using a complex comprising an HLA class I molecule and an attaching means
Lapsed on the fee record
Ended Sep 4, 2015 · USPTO record
Lapsed on the fee recordEnded Sep 4, 2015USPTO record
US 7,521,197Method for producing cytotoxic T-cells
Lapsed on the fee record
Ended Apr 21, 2013 · USPTO record
Lapsed on the fee recordEnded Apr 21, 2013USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited